SY So-Young International Inc: Company Value to Revenue Ratio

So-Young International Inc. (SY) - corporate logo

Regulatory risks in the aesthetics sector and a decline in consumer spending on plastic surgery are weighing on the revenues of So-Young International (SY). The EV/Sales ratio demonstrates a stabilization of quotes, where the value of 420.69 corresponds to the current metric. This is occurring against a backdrop of recovering demand in China and a struggle with US geopolitical pressure, which limits the expansion of the Chinese MedTech service into foreign markets.

SY (So-Young International Inc.) EV/Sales Multiple history from 11/23/2025 to 11/20/2026

SY (So-Young International): analytical breakdowns and indicator data

- market price and analyst price targets:
- cash and cash flow indicators:
Fundamental company valuation:SY - So-Young International Inc.
Product sample of So-Young Corp

Investors seek objective asset valuation benchmarks within financial statements. The EV/Sales metric compares the total enterprise value, including debt, against annual revenue. By analyzing the EV to revenue ratio of a company, one can assess the market premium paid for generated cash flows. For So-Young International (SY), the use of cloud outsourcing reduces capital expenditures, impacting the cost structure. This chart's price action helps determine whether the current price is a result of undervaluation or sector stagnation.

Direct competitors

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|agilon health Inc - Company Value to Revenue|absci.com - Enterprise Value-to-Revenue Ratio|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)